| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |